Select Page

India launches the world’s first COVID-19 intranasal vaccine, iNCOVACC made by Bharat Biotech. It is available on the CoWin platform. The doses are to be administered in a gap of 28 days. The Indian drug regulators initially approved it for emergency uses only for people in the age group of 18 years and above but now it is widely available in all government and private hospitals.

Read the original article here: